|ACPM Headlines 5/20/11|
Policy and Practice
Research and Reports
1. ACPM LAUNCHES MEDICATION ADHERENCE TIME TOOL
ACPM is pleased to announce the launch of the Medication Adherence Time Tool. Developed by ACPM with an unrestricted grant from the Pharmaceutical Research and Manufacturers of America (PhRMA), this Time Tool aims to improve prescription medicine adherence and health outcomes across all populations by focusing on the role providers can play in helping their patients take their medications.
It is estimated between 20% and 50% of patients are non-adherent with their provider's medical advice, and studies have shown that over 183 million office visits can be prevented through better communication between patients and physicians.
This Time ToolTM is the second in a series of three related tools ACPM is developing on medication use and abuse, including both prescription and over-the-counter (OTC) medications. The Use, Abuse, Misuse and Disposal of Prescription Pain Medication Time Tool was the first in the series to launch in January, and a tool on use, misuse, abuse, and storage of OTC medications will be released in the coming months. View ACPM's library of Time Tools.
ACPM leaders met with the Deputy Surgeon General, RADM Boris Lushniak, MD, MPH, and the Surgeon General’s Chief of Staff, RADM Christopher Halliday, DDS, MPH, this week to discuss the Surgeon General’s priority issues and explore synergies with key elements of ACPM’s advocacy agenda. The chief issues discussed were lifestyle medicine and prescription drug abuse. ACPM organized the meeting in response to Surgeon General RADM Regina Benjamin’s call for a more substantive relationship with ACPM and its new Academy partner, the American College of Lifestyle Medicine, at the Preventive Medicine 2011conference in San Antonio this past February, where she provided a plenary presentation at the ACPM Town Hall Forum.
ACPM President Miriam Alexander, MD, MPH, FACPM, executive director Michael Barry, and associate executive director Paul Bonta attended the meeting on behalf of ACPM, shared the recent JAMA commentary on lifestyle medicine competencies spearheaded by ACPM and ACPM’s recent Time Tool on pain medication use and abuse, and discussed with the SG’s senior staff the potential for the Surgeon General to issue a "Call to Action” related to either of the two issues. The SG periodically issues a "Call to Action” to raise awareness among the general public of a health issue or concern and galvanize the broad community to take action.
Treating HIV-infected people with oral antiretroviral medicine significantly reduces transmission to sexual partners, according to new results from a large-scale clinical study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The $73 million study, conducted in nine countries, was funded by the National Institutes of Health and led by Myron Cohen, director of the Institute for Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill.
The randomized trial of 1,763 couples—in which one partner had HIV and the other didn't—confirms a growing body of less rigorous research and is likely to inject new urgency into treatment campaigns. A global effort now underway to treat millions of patients with antiretroviral drugs could have the added benefit of slowing the spread of HIV.
Read more about the study here: http://www.niaid.nih.gov/news/QA/Pages/HPTN052qa.aspx
4. ACPM PERSPECTIVES IN PREVENTION: "TRAVEL AND HEALTH” AVAILABLE ONLINE FOR CME
ACPM’s Perspectives in Prevention column, "Travel and Health,” byCathey Falvo, MD, MPH, is now available online for CME on Medscape/WebMD. The article provides information on travel health risks and practical guidelines to help healthcare professionals effectively counsel travelers and prevent travel-borne illness. The article offers advice for preparing patients to travel and avoiding potential health problems that may occur while traveling or post-travel, and recommends ways for treating conditions associated with traveling abroad.
Click to read the full article and access ACPM’s complete compilation of Perspectives in Prevention articles.
ACPM is preparing to host the next meeting of the National Coalition for Adolescent Health, scheduled for June 29, 2011, in Washington, DC. Led by Chair and ACPM FellowArthur Elster,MD, FACPM, the coalition is comprised of national health professional, advocacy, and research organizations that have active programming in adolescent health issues or identify adolescent health improvement as an important goal of the organization. ACPM convenes the coalition annually with support from a cooperative agreement with Health Resources and Services Administration's Maternal and Child Health Bureau.
This year's meeting will focus on adolescent reproductive health. To learn more about the coalition, please visit http://www.acpm.org/ah/AHCoalition.htm.
Need relevant CME or MOC and just aren’t sure where to find it? Well, you are in luck! All ACPM members can obtain hundreds of hours of free CME and MOC credit on the ACPM website.
Nearly 70 hours of CME and MOC are available from Preventive Medicine 2011 on the ACPM E-portal,plus an additional 55 hours from the Preventive Medicine Board Review Course; two new articles are available for CME and MOC in every edition ofAJPM; nine Time Tools are available, each offering one hour of CME and MOC; eight Perspectives in Prevention columns offer CME; and various webinars on topics ranging from asthma management to lifestyle medicine can be found on ACPM’s CME/MOC center.
This month’s issue of AJPM features two articles offering CME credit:
In addition, two articles slated for the upcoming June issue ofAJPMalready have been released onwww.ajpmonline.organd offer CME:
ACPM’s Events Calendar is another rich source of CME and other educational events of interest to preventive medicine physicians from organizations other than ACPM. This month’s featured CME offering is from the University of Wisconsin, which is offering a free, one-hour online program on "Treating Tobacco Use and Dependence,” based on the Public Health Service guideline of the same name. For more information on the program, please visithttp://www.ctri.wisc.edu/HC.Providers/CMEflyer.pdf.
7. SENATORS ASK COMMITTEE TO INCREASE FUNDING FOR PMR PROGRAMS
Ten Senators, led by Sen. Tom Udall (D-NM), delivered a letter to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies urging $10 million be made available in the FY 2012 budget to the Health Resources and Services Administration’s (HRSA’s) "Public Health and Preventive Medicine account to support preventive medicine residency training programs.” Currently, the "Public Health and Preventive Medicine” account is funded at $9.6 million and is divided between preventive medicine residency (PMR) training programs, public health training centers, and public health traineeships. The portion of funding provided to PMR programs is $2.3 million.
ACPM greatly appreciates Sen. Tom Udall’s (D-NM) efforts in leading the charge to build support for preventive medicine residency training programs in the Senate and for his broader efforts in support of the entire public health community. This is the second year in a row that Sen. Udall (D-NM) has led this effort.
The Partnership to Fight Chronic Disease (PFCD), a broad-based national coalition organized to promote the prevention of chronic disease, recently held a Capitol Hill briefing where ACPM’s Time Tools on Medication Adherence and Use, Abuse, Misuse and Disposal of Prescription Pain Medications were highlighted as models of targeted programs that must be developed to help address the growing epidemic of prescription drug use and other medication use problems. ACPM has long been an active member of PFCD and maintains a seat on its Advisory Board.
The U.S. Food and Drug Administration (FDA) has approved a new prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Linagliptin tablets, packaged under the label of Tradjenta™ byBoehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company, can be used as monotherapy or in combination with other commonly prescribed medications for type 2 diabetes — metformin, sulfonylurea or pioglitazone.
TRADJENTA is the first member of a class of prescription medications called dipeptidyl peptidase-4 (DPP-4) inhibitors to be approved at one dosage strength (5 mg, once daily).TRADJENTA is not indicated for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (increased ketones in the blood or urine), and has not been studied in combination with insulin.
10. HHS RELEASES ACTION PLAN TO PREVENT & TREAT VIRAL HEPATITIS
The U.S. Department of Health and Human Services has launched an action plan to prevent and treat viral hepatitis, a silent epidemic affecting 3.5 – 5.3 million Americans. The plan—Combating the Silent Epidemic: US Department of Health and Human Services Action Plan for the Prevention, Care and Treatment of Viral Hepatitis—is a response to the January 2010 Institute of Medicine (IOM) report on hepatitis, highlighting barriers impeding efforts for hepatitis prevention and control.
The HHS plan outlines a comprehensive action plan to raise awareness about viral hepatitis; creates more opportunities to train health professionals to diagnose, treat, vaccinate, and ultimately save lives; and builds upon the new health insurance reform law to improve patient access to comprehensive viral hepatitis-related prevention and treatment services through expanded coverage.
For more information and to view the HHS plan: http://www.hhs.gov/ash/initiatives/hepatitis/.
Anew studyfinds that simply making physicians aware of the cost of regular blood tests cut the daily bill for the tests by as much as 27%. Published in the May issue ofArchives of Surgery, the study showed that after educating surgical house-staff and attending physicians on the cost of routine blood studies for non-intensive care surgical inpatients, there was a decrease in ordering of laboratory tests and a savings for the hospital from $147.73/patient/day to $118.83/patient/day at the conclusion of the study.
The study is available at: http://archsurg.ama-assn.org/current.dtl.
The Robert Wood Johnson Foundation has released a report, "Strengthening the Performance and Impact of Public Health Departments,” highlighting progress of its national initiative to invest in public health services and systems research (PHSSR). The report features the work of its major grantee, the University of Kentucky, led by ACPM FellowF. Douglas Scutchfield, MD, MPH, FACPM, and three public health practice associations—the National Association of County and City Health Officials (NACCHO), the Association of State and Territorial Health Officials (ASTHO) and the National Association of Local Boards of Health (NALBOH).
RWJF’s PHSSR initiative supports projects to create, expand and promote use of a database of research about public health services and systems; increase the number of researchers interested in public health services and systems research; and develop and sustain the capacity of the three practice organizations to collect and analyze timely, comparable data on the structure and characteristics of their member agencies and, thereby, of the nation’s public health services and systems.
To view the progress report and read more about the initiative, visit: http://www.rwjf.org/files/research/PHEB.final.pdf.
Table of Contents
13. COMMISSION TO END HEALTH CARE DISPARITIES ISSUES WHITE PAPER
The Commission to End Health Care Disparities has released a white paper entitled "Collecting and using race, ethnicity and language data in ambulatory settings:A white paper with recommendations from the Commission to End Health Care Disparities.”
The reportprovides a set of detailed recommendations for collecting and using patient demographic data in the ambulatory setting. These recommendations are intended to guide not only physicians and health professionals, but also vendors of electronic health record (EHR) systems, policymakers, purchasers, hospitals, health plans and others.
ACPM FellowRobert Gilchick, MD, MPH, is ACPM’s representative to the Commission.
To view the report, please visit: http://www.ama-assn.org/resources/doc/public-health/cehcd-redata.pdf.
The U.S. Department of Health and Human Services has announced the availability of over $100 million in funding for up to 75 Community Transformation Grants. Created by the Affordable Care Act, these grants are aimed at helping communities implement projects proven to reduce chronic diseases such as diabetes and heart disease. By promoting healthy lifestyles and communities, especially among population groups experiencing the greatest burden of chronic disease, these grants will help improve health, reduce health disparities, and lower health care costs.
For more information about this grant opportunity, please visit: http://www.grants.gov/search/search.do?oppId=93873&mode=VIEW.
15. JAMA COMMENTARY: PUBLIC HEALTH IMPLICATIONS OF GOVERNMENT SPENDING REDUCTIONS
The May 18, 2011 issue ofJAMAfeatures commentary from ACPM FellowSteve Woolf, MD, MPH,on the public health implications of government spending reductions. You can read the full article (you must have a subscription to the AMA) at http://jama.ama-assn.org/content/305/18/1902.extract.